Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Repeat selective laser trabeculoplasty.

Bryan Kun Hong1, Jeffrey C Winer, James F Martone

  • 1Yale University School of Medicine, New Haven, CT, USA.

Journal of Glaucoma
|March 20, 2009
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inpatient Pediatric Blood Pressure Monitoring: Upper vs Lower Extremity Measurements.

Hospital pediatrics·2025
Same author

Characteristics of Pediatric Hospital Medicine Fellowship Program Directors.

Hospital pediatrics·2024
Same author

(How) do we need to monitor stabilized patients with bronchiolitis?

Journal of hospital medicine·2023
Same author

Effect Modifiers of the Association of High-Flow Nasal Cannula and Bronchiolitis Length of Stay.

Hospital pediatrics·2023
Same author

Kidney failure outcomes in children and young adults with sickle cell disease in the United States Renal Data System.

Pediatric nephrology (Berlin, Germany)·2023
Same author

End Stage Kidney Disease Outcomes in Children and Young Adults with Sickle Cell Disease in the United States Renal Data System.

Research square·2023
Same journal

Tonographic outflow facility and intraocular pressure after standalone OMNI surgery.

Journal of glaucoma·2026
Same journal

Factors Associated With Retinal Nerve Fiber Layer Asymmetry in Primary Open-Angle Glaucoma Among Individuals of African Ancestry.

Journal of glaucoma·2026
Same journal

Haploinsufficiency of PITX2 in Four Chinese Families with Axenfeld-Rieger Syndrome.

Journal of glaucoma·2026
Same journal

Intraocular Pressure-Lowering Effect of Omidenepag Isopropyl as a Predictor for the Efficacy of Laser Trabeculoplasty.

Journal of glaucoma·2026
Same journal

Comparative Outcomes Between Micropulse and Slow-Coagulation Transscleral Cyclophotocoagulation in Eyes With Good Visual Acuity.

Journal of glaucoma·2026
Same journal

Machine Learning With Optical Coherence Tomography for Glaucoma Diagnosis.

Journal of glaucoma·2026
See all related articles

Repeat 360-degree selective laser trabeculoplasty (SLT) is safe and effective for glaucoma patients when initial treatment fails. This repeat SLT can achieve results as early as six months after the first procedure.

Area of Science:

  • Ophthalmology
  • Glaucoma Management
  • Laser Therapy

Background:

  • Glaucoma is a leading cause of irreversible blindness worldwide.
  • Selective Laser Trabeculoplasty (SLT) is a common laser procedure to lower intraocular pressure (IOP).
  • The long-term efficacy of repeat SLT after initial success has not been fully established.

Purpose of the Study:

  • To evaluate the efficacy and safety of repeat 360-degree SLT in glaucoma patients.
  • To compare the IOP-lowering effect of initial SLT (SLT1) versus repeat SLT (SLT2).
  • To determine if the timing of repeat SLT influences outcomes.

Main Methods:

  • Retrospective chart review of 44 eyes from 35 patients with open-angle glaucoma.
  • Patients had previously undergone a successful 360-degree SLT (SLT1) that lost efficacy.

Related Experiment Videos

  • Repeat 360-degree SLT (SLT2) was performed, with IOP measurements recorded at various time points post-treatment.

    • Main Results:

    • Repeat SLT (SLT2) showed a significantly less IOP reduction at 1-3 months compared to SLT1 (-2.9 mm Hg vs. -5.0 mm Hg).
    • However, overall success rates (≥20% IOP reduction) were not significantly different between SLT1 and SLT2.
    • No significant difference in outcomes was observed based on the timing of the repeat SLT (6-12 months vs. >12 months after SLT1).

    Conclusions:

    • Repeat 360-degree SLT appears to be a safe and effective option for glaucoma patients whose initial SLT treatment has lost efficacy.
    • The IOP reduction may be less pronounced with repeat treatment, but success rates remain comparable.
    • Repeat SLT can be considered as an early treatment option, potentially as soon as six months after the initial procedure.